Turnstone Biologics Corp. Stock Split Ratio
Turnstone Biologics Corp. had Stock Split Ratio of 12.52% as of 2023-07-25, per its 10-K filed 2024-03-22.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-03-22
- 2023-07-25: Stockholders' Equity Note, Stock Split, Conversion Ratio 12.52%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2023-07-25 | 12.52% 10-K · filed 2024-03-22 |